Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 1
2018 2
2019 3
2020 3
2021 6
2022 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Flare on [18F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients.
Malaspina S, Ettala O, Tolvanen T, Rajander J, Eskola O, Boström PJ, Kemppainen J. Malaspina S, et al. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):613-621. doi: 10.1007/s00259-022-05970-y. Epub 2022 Sep 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 36161511 Free PMC article.
Diagnostic Accuracy of 18F-FDG-PET/CT and 18F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI.
Murtojärvi S, Malaspina S, Kinnunen I, Tuokkola T, Honka MJ, Saunavaara V, Tolvanen T, Schrey A, Kemppainen J. Murtojärvi S, et al. Among authors: malaspina s. Contrast Media Mol Imaging. 2022 Aug 24;2022:8676787. doi: 10.1155/2022/8676787. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 36082064 Free PMC article.
Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regional, and segmental levels.
Nesterov SV, Deshayes E, Juarez-Orozco LE, deKemp RA, Sciagrà R, Malaspina S, Settimo L, Han C, Ryzhkova DV, Kostina IS, Gwet KL, Prior JO, Knuuti JM. Nesterov SV, et al. Among authors: malaspina s. Ann Nucl Med. 2022 Jun;36(6):507-514. doi: 10.1007/s12149-022-01729-5. Epub 2022 Feb 22. Ann Nucl Med. 2022. PMID: 35192160 Free PMC article.
Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
Arvola S, Seppänen M, Malaspina S, Mätzke S, Raiko J, Timonen KL, Ettala O, Jambor I, Anttinen M, Kuisma A, Löyttyniemi E, Boström PJ, Sohlberg A, Noponen T. Arvola S, et al. Among authors: malaspina s. Nucl Med Commun. 2022 May 1;43(5):510-517. doi: 10.1097/MNM.0000000000001536. Nucl Med Commun. 2022. PMID: 35081092 Free article.
Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer.
Malaspina S, Anttinen M, Taimen P, Löyttyniemi E, Kemppainen J, Seppänen M, Boström P, Ettala O. Malaspina S, et al. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2672-2673. doi: 10.1007/s00259-021-05428-7. Epub 2021 Jun 14. Eur J Nucl Med Mol Imaging. 2021. PMID: 34128091 No abstract available.
Kinetic analysis and optimisation of 18F-rhPSMA-7.3 PET imaging of prostate cancer.
Malaspina S, Oikonen V, Kuisma A, Ettala O, Mattila K, Boström PJ, Minn H, Kalliokoski K, Postema EJ, Miller MP, Scheinin M. Malaspina S, et al. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3723-3731. doi: 10.1007/s00259-021-05346-8. Epub 2021 Apr 12. Eur J Nucl Med Mol Imaging. 2021. PMID: 33846844 Free PMC article.
19 results